Funding Rounds · Grant

Ability Pharmaceuticals — Grant · €2.5M

The EU's EIC Accelerator awarded AbilityPharma €5M in total: a €2.5M grant plus €2.5M in equity from investors selected by the European Investment Bank. The money funds a Phase 2b trial of ABTL0812 with chemotherapy in advanced pancreatic cancer. Existing shareholders include Inveready, Everis and Sodena.

LeadEIC Fund RoundGrant Announced16 Mar 2020Not counted in totals CityCerdanyola del Vallès SectorBiotechSource

Something wrong? Suggest a correction →

The company

Ability Pharmaceuticals
abilitypharma.com
Now Series A Cerdanyola del Vallès

Investors 1

EIC Fund
eic.ec.europa.eu
LeadLuxembourg

← All funding rounds

Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list